“Targeting mTORC1 and AMPK Signaling: Potential Therapeutic Approaches for Idiopathic Pulmonary Fibrosis”, AWMR, vol. 2, no. 1, pp. 1–20, Feb. 2026, doi: 10.71204/99f36029.